POWELL MICHAEL

CIK 000120279332 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001202793

Recent Transactions

50 trades

Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-06-09+19,475→ 19,475 total
Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-06-09+23,746→ 23,746 total
Award
Galera Therapeutics, Inc.$GRTX
Stock Option (Right to Buy)
2023-06-14+64,000→ 64,000 total
Award
Galera Therapeutics, Inc.$GRTX
Stock Option (Right to Buy)
2022-06-15+20,000→ 20,000 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−30,000→ 0 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−30,000→ 0 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−10,030→ 0 total
Award
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-08-09+30,000→ 30,000 total
Award
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-06-16+10,030→ 10,030 total
Award
Galera Therapeutics, Inc.$GRTX
Stock Option (Right to Buy)
2021-06-16+13,179→ 13,179 total
Award
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-11-10+30,000→ 30,000 total
Conversion
Checkmate Pharmaceuticals, Inc.
Series C Preferred Stock
2020-08-11−3,644,624→ 0 total
Conversion
Checkmate Pharmaceuticals, Inc.
Common Stock
2020-08-11+3,473,374→ 3,473,374 total
Conversion
Checkmate Pharmaceuticals, Inc.
Series B Preferred Stock
2020-08-11−8,753,350→ 0 total
Conversion
Checkmate Pharmaceuticals, Inc.
Series A Preferred Stock
2020-08-11−12,500,000→ 0 total
Purchase
Checkmate Pharmaceuticals, Inc.
Common Stock
2020-08-11$15.00/sh+133,333→ 3,606,707 total
Award
Galera Therapeutics, Inc.$GRTX
Stock Option (Right to Buy)
2020-06-09+13,179→ 13,179 total
Award
Galera Therapeutics, Inc.$GRTX
Stock Option
2019-11-06+19,776→ 19,776 total
Award
SYNLOGIC, INC.$SYBX
Stock Option (right to buy)
2019-06-05+10,000→ 10,000 total
Award
SYNLOGIC, INC.$SYBX
Stock Option (right to buy)
2018-06-13+10,000→ 10,000 total
Award
SYNLOGIC, INC.$SYBX
Common Stock
2018-01-26$9.75/sh+150,000→ 574,972 total
Award
SYNLOGIC, INC.$SYBX
Stock Option (right to buy)
2017-12-29+18,572→ 18,572 total
Award
SYNLOGIC, INC.$SYBX
Stock Option (right to buy)
2017-08-28+1,428→ 1,428 total
Other
Ocera Therapeutics, Inc.
Common Stock
2016-10-31−9,540→ 0 total
Other
Ocera Therapeutics, Inc.
Common Stock
2016-10-31−138,686→ 0 total
Other
Ocera Therapeutics, Inc.
Common Stock
2016-10-31−699,996→ 0 total
Other
Ocera Therapeutics, Inc.
Common Stock
2016-10-31+14,328→ 14,328 total
Sale
Ocera Therapeutics, Inc.
Common Stock
2016-09-12$2.29/sh−5,372→ 699,996 total
Exercise of In-Money
Ocera Therapeutics, Inc.
Stock warrant (right to buy)
2016-09-12−9,187→ 0 total
Exercise of In-Money
Ocera Therapeutics, Inc.
Common Stock
2016-09-12$0.67/sh+18,374→ 705,368 total
Sale
Ocera Therapeutics, Inc.
Common Stock
2016-09-12$2.29/sh−1,066→ 138,686 total
Sale
Ocera Therapeutics, Inc.
Common Stock
2016-09-12$2.29/sh−74→ 9,540 total
Exercise of In-Money
Ocera Therapeutics, Inc.
Stock warrant (right to buy)
2016-09-12−9,187→ 0 total
Exercise of In-Money
Ocera Therapeutics, Inc.
Common Stock
2016-09-12$0.67/sh+250→ 9,614 total
Exercise of In-Money
Ocera Therapeutics, Inc.
Stock warrant (right to buy)
2016-09-12−1,820→ 0 total
Exercise of In-Money
Ocera Therapeutics, Inc.
Stock warrant (right to buy)
2016-09-12−1,820→ 0 total
Exercise of In-Money
Ocera Therapeutics, Inc.
Stock warrant (right to buy)
2016-09-12−125→ 0 total
Exercise of In-Money
Ocera Therapeutics, Inc.
Stock warrant (right to buy)
2016-09-12−125→ 0 total
Exercise of In-Money
Ocera Therapeutics, Inc.
Common Stock
2016-09-12$0.67/sh+3,640→ 139,752 total
Sale
Ocera Therapeutics, Inc.
Common Stock
2016-07-29$2.53/sh−11,969→ 0 total
Exercise/Conversion
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2016-07-11−11,969→ 0 total
Exercise/Conversion
Ocera Therapeutics, Inc.
Common Stock
2016-07-11$1.26/sh+11,969→ 11,969 total
Award
SYNLOGIC, INC.$SYBX
Stock Option (Right to Buy)
2016-06-29+10,000→ 10,000 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2016-06-14+12,500→ 12,500 total
Purchase
SYNLOGIC, INC.$SYBX
Common Stock
2015-10-06$7.00/sh+857,142→ 2,974,811 total
Other
SYNLOGIC, INC.$SYBX
Common Stock
2015-10-06+289,841→ 2,117,669 total
Conversion
SYNLOGIC, INC.$SYBX
Series C Preferred Stock
2015-10-05−1,244,269→ 0 total
Conversion
SYNLOGIC, INC.$SYBX
Series D Preferred Stock
2015-10-05−583,559→ 0 total
Conversion
SYNLOGIC, INC.$SYBX
Common Stock
2015-10-05+1,244,269→ 1,244,269 total
Conversion
SYNLOGIC, INC.$SYBX
Common Stock
2015-10-05+583,559→ 1,827,828 total

Companies

Recent Filings

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116

View on SEC.gov